Psychemedics Corporation
Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy… Read more
Psychemedics Corporation (PMD) - Total Assets
Latest total assets as of September 2024: $9.84 Million USD
Based on the latest financial reports, Psychemedics Corporation (PMD) holds total assets worth $9.84 Million USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Psychemedics Corporation - Total Assets Trend (1987–2023)
This chart illustrates how Psychemedics Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Psychemedics Corporation - Asset Composition Analysis
Current Asset Composition (December 2023)
Psychemedics Corporation's total assets of $9.84 Million consist of 55.2% current assets and 44.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.9% |
| Accounts Receivable | $3.71 Million | 30.1% |
| Inventory | $1.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1987–2023)
This chart illustrates how Psychemedics Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Psychemedics Corporation's current assets represent 55.2% of total assets in 2023, an increase from 50.0% in 1987.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2023, down from 40.0% in 1987.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1987.
- Asset Diversification: The largest asset category is accounts receivable at 30.1% of total assets.
Psychemedics Corporation Competitors by Total Assets
Key competitors of Psychemedics Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Psychemedics Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Psychemedics Corporation generates 1.79x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Psychemedics Corporation is currently not profitable relative to its asset base.
Psychemedics Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | 1.46 | 2.20 |
| Quick Ratio | 1.59 | 1.46 | 2.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.25 Million | $ 2.49 Million | $ 7.02 Million |
Psychemedics Corporation - Advanced Valuation Insights
This section examines the relationship between Psychemedics Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.53 |
| Latest Market Cap to Assets Ratio | 0.93 |
| Asset Growth Rate (YoY) | -34.2% |
| Total Assets | $12.33 Million |
| Market Capitalization | $11.49 Million USD |
Valuation Analysis
Near Book Valuation: The market values Psychemedics Corporation's assets close to their book value ( 0.93x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Psychemedics Corporation's assets decreased by 34.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Psychemedics Corporation (1987–2023)
The table below shows the annual total assets of Psychemedics Corporation from 1987 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $12.33 Million | -34.20% |
| 2022-12-31 | $18.73 Million | -13.08% |
| 2021-12-31 | $21.55 Million | -10.21% |
| 2020-12-31 | $24.00 Million | -12.81% |
| 2019-12-31 | $27.53 Million | +10.24% |
| 2018-12-31 | $24.97 Million | -5.79% |
| 2017-12-31 | $26.51 Million | +5.90% |
| 2016-12-31 | $25.03 Million | +11.94% |
| 2015-12-31 | $22.36 Million | -7.12% |
| 2014-12-31 | $24.08 Million | +45.49% |
| 2013-12-31 | $16.55 Million | +17.20% |
| 2012-12-31 | $14.12 Million | +2.32% |
| 2011-12-31 | $13.80 Million | +17.29% |
| 2010-12-31 | $11.77 Million | +10.98% |
| 2009-12-31 | $10.60 Million | -16.04% |
| 2008-12-31 | $12.63 Million | -18.85% |
| 2007-12-31 | $15.56 Million | +17.34% |
| 2006-12-31 | $13.26 Million | +18.98% |
| 2005-12-31 | $11.15 Million | +32.15% |
| 2004-12-31 | $8.43 Million | +16.05% |
| 2003-12-31 | $7.27 Million | -10.09% |
| 2002-12-31 | $8.08 Million | -11.26% |
| 2001-12-31 | $9.11 Million | -17.63% |
| 2000-12-31 | $11.06 Million | -22.13% |
| 1999-12-31 | $14.20 Million | -24.06% |
| 1998-12-31 | $18.70 Million | -1.06% |
| 1997-12-31 | $18.90 Million | +20.38% |
| 1996-12-31 | $15.70 Million | +53.92% |
| 1995-12-31 | $10.20 Million | -0.97% |
| 1994-12-31 | $10.30 Million | +134.09% |
| 1993-12-31 | $4.40 Million | +46.67% |
| 1992-12-31 | $3.00 Million | -9.09% |
| 1991-12-31 | $3.30 Million | +120.00% |
| 1990-12-31 | $1.50 Million | +36.36% |
| 1989-12-31 | $1.10 Million | +10.00% |
| 1987-12-31 | $1.00 Million | -- |